Russian institute claims success in human trial of Covid-19 vaccine

United States News News

Russian institute claims success in human trial of Covid-19 vaccine
United States Latest News,United States Headlines
  • 📰 IOL
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

A Russian institute developing a potential coronavirus vaccine hopes to start its final stage testing in mid-August after a successful trial on nine volunteers. CoronvirusPandemic Covid19

Moscow - A Russian institute developing one of the country's potential coronavirus vaccines hopes to start its final stage testing in a small section of the general public in mid-August, the RIA news agency cited the institute's director as saying on Monday.

Early results from the first small-scale human trial of the vaccine developed by the Gamaleya Institute in Moscow has shown it to be safe for use, according to a separate RIA report on Sunday. This will be equivalent to a Phase III trial, since people getting the vaccine will remain under supervision, RIA reported, citing Ginsburg.

Human trials of the Gamaleya Institute's vaccine began on June 18, with nine volunteers receiving one dose, and another nine testing the prospective booster dose.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

IOL /  🏆 46. in ZA

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Russia may start phase III trial of Covid-19 vaccine in mid-AugustA Russian institute developing one of the country’s potential coronavirus vaccines hopes to start its final stage testing in a small section of the general public in mid-August, the RIA news agency cited the institute’s director as saying on Monday. Globally, of 19 experimental COVID-19 vaccines in human trials, only two are in final Phase III trials — one by China’s Sinopharm and another by AstraZeneca and the University of Oxford.
Read more »

COVID-19: More people needed for vaccine trial - ExpertCOVID-19: More people needed for vaccine trial - ExpertSome participants tested positive for the virus, and others were excluded because of underlying illnesses.
Read more »

SA's first Covid-19 vaccine trial brings hopeThe AU-commissioned programme intends to have injection by first quarter of next year.
Read more »

SA moves into global top 10 for Covid-19 cases, with 13,497 new infectionsSA has 264,184 confirmed cases of Covid-19, the tenth highest number of infections globally.
Read more »

East London man, 90, recovers from Covid-19, thanks nurses for their sacrificeA 90-year-old East London man has recovered from Covid-19 - and gives full credit to the nurses who cared for him during his ordeal
Read more »

Pregnant women can pass Covid-19 to their unborn babies — new studyThe evidence that pregnant women may pass the Covid-19 virus to their unborn babies is gaining momentum, with a new Italian study confirming the vertical in utero transmission.
Read more »



Render Time: 2025-03-09 18:20:59